Home' Australian Pharmacist : Australian Pharmacist September 2014 Contents Australian Pharmacist September 2014 I © Pharmaceutical Society of Australia Ltd.
Webstercare’s range of
Webster-pak and Unit Dose 7
Webstersystem Folders received a
Finalists Award at the recent Good
Design Australia Awards in the
Webstercare Managing Director Gerard
Stevens said, ‘this is the first time since
we launched nearly 30 years ago that
the Webster-pak folder range has
been redesigned. We are very proud
of our history of innovation and are
always asking ourselves how we can
improve. We’ve applied this principle
to our Webster-pak Folder Range and
are delighted the new range has been
recognised by Good Design Australia.’
Some of the key features and/or benefits
of the range which has been designed
to improve all aspects of the user
• Larger header card window at the top
of the folder allows pharmacies to
include their own branding.
• The folders are pre-labelled
during the manufacturing process
eliminating the need for the user to
apply a label themselves creating a
more efficient and consistent result.
• The new range has been designed
to seamlessly integrate with existing
products within the extensive system,
such as storage solutions, blister
packaging and header card stationery.
• The folder range has been
manufactured with Antimicrobial
Technology which provides safe,
effective and permanent protection
against bacterial build-up reducing
the risk of cross-contamination or
harmful species such as MRSA, E.Coli
and Legionella – a constant battle in
hospitals and care homes worldwide
1. Rennard SI. Chronic obstructive pulmonary disease:
definition, clinical manifestations, diagnosis, and staging.
Up To Date; 2014. At: www.uptodate.com/contents/
2. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax.
3. Morisky DE, Green LW, Levine DM. Concurrent and
predictive validity of a self-reported measure of medication
adherence. Medical Care. 1986;24(1):67–74 .
4. Khadour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay
JC. Potential risk factors for medication non-adherence
in patients with chronic obstructive pulmonary disease
(COPD). Eur J Clin Pharmacol. 2012;68:1365–73.
5. McIvor RA, Tunks M, Todd DC. COPD. Clinical Evidence.
6. Abramson M, Glasgow N, McDonald C. Managing chronic
obstructive pulmonary disease. Aust Prescr. 2007;30:64–7 .
7. Global Initiative for Chronic Obstructive Lung Disease:
Global strategy for the diagnosis, management, and
prevention of chronic obstructive pulmonary disease,
2013. At: www.goldcopd.org/uploads/users/files/GOLD_
8. Australian Government Department of Health.
Influenza (flu), 2013. At: www.immunise.health.gov.au/
9. Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute
respiratory illness in patients with COPD and the
effectiveness of influenza vaccination. Chest.
10. Australian Government Department of Health.
Pneumococcal disease, 2014. At: www.immunise.health.
References from APSIG column on page 24.
The folders have reusable folder frames
which gives 65% reduction in waste
Mr Stevens said the colour coding
system was an important part,
ensuring the dosage times were
easily recognisable. Different dosage
times and medication categories have
different coloured folders for quick and
easy identification and have also been
designed to match the co-ordinating
medication chart systems.
‘ The folders have enhanced colours in
easy to identify vibrant colours which
have been standardised across the
range to create a more consistent and
cohesive look. We believe this creates a
safer environment for all areas of use –
pharmacy, personal, aged care,’ he said.
A valuable addition
Russell Hill, APHS
Australia, has been
appointed to the
Stuart Giles, APHS Executive Chairman
said: ‘Russell’s clinical experience
in Australia and overseas makes
him an invaluable addition to the
APHS Advisory Board. His extensive
knowledge of current practice,
combined with his experiences in the
UK, bring a fresh perspective to a highly
During in his time in the UK, Russell
was heavily involved in the review
and modernisation of hospital
pharmacy practices, including research
into strategic public and private
partnerships. He continues his interest in
developing the pharmacy profession as
a Board Director for the Pharmaceutical
Society of Australia.
The Advisory Board played a core role in
APHS’ strategic direction over the past
five years, including the evolution of
APHS Packaging and Icon Cancer Care as
part of the wider group strategy.
Links Archive Australian Pharmacist October 2014 Australian Pharmacist August 2014 Navigation Previous Page Next Page